The nation’s top public health agency on Thursday relaxed its COVID-19 guidelines, dropping the recommendation that Americans quarantine themselves if they come into close contact with an infected person.
President Joe Biden tested positive for COVID-19 for the second straight day, in what appears to be a rare case of “rebound” following treatment with an anti-viral drug.
Pfizer and Moderna expect to have updated versions of their shots available as early as September, the Food and Drug Administration said in a statement.
President Joe Biden’s administration is launching a renewed push for COVID-19 booster shots for those eligible, pointing to the enhanced protections they offer against severe illness as the highly transmissible BA.5 variant spreads across the country.
Researchers also found only 17 percent of parents of children between 6 months and 5 years old said their child has been vaccinated or will be as soon as possible.
After participating in a virtual meeting to talk about computer chip manufacturing, Biden said “everything’s on the button” with the medical tests he’s been receiving each evening.
Some school systems around the country have moved to bolster staffing to minimize disruptions, but many are hoping for the best without doing much else differently compared with last year.
Administration officials have emphasized that Biden's symptoms are mild because he has received four vaccine doses, and he started taking the antiviral drug Paxlovid.
The rapidly spreading BA.5 subvariant is now causing about 80% of new COVID-19 infections in the U.S., according to new data from the Centers for Disease Control and Prevention.
The symptoms could be a headache, a runny nose, a sore throat, as well as loss of smell, taste or hair. Some could even struggle with fatigue, chills or fever.
Across the country, more than 100,000 new cases have been reported every day over the past two weeks, but experts say that number could actually be higher.
Government advisers debated Tuesday if Americans should get a modified COVID-19 booster shot this fall, and exactly how best to update it to fight a virus that surely will change even more by then.
In a reversal for President Joe Biden, a federal appeals court in New Orleans on Monday agreed to reconsider its own April ruling that allowed the administration to require federal employees to be vaccinated against COVID-19.
Pfizer says either an omicron-targeted booster or a combination shot that mixes the original vaccine with omicron protection substantially increases protection.
A senior administration official said the mandate expires Sunday at 12:01 a.m. ET, saying the Centers for Disease Control and Prevention has determined that it’s no longer necessary.
A COVID-19 vaccine that could soon win federal approval may offer a boost for the U.S. military: an opportunity to get shots into some of the thousands of service members who have refused the other coronavirus vaccines for religious reasons.
Negotiations for more funding broke down earlier this year over President Joe Biden’s plans to end pandemic-related public health restrictions on U.S. borders that severely curtailed migration.
